Five Prime Therapeutics Inc. (FPRX) is priced at $14.96 after the most recent trading session. At the very opening of the session, the stock price was $16.27 and reached a high price of $16.34, prior to closing the session it reached the value of $16.37. The stock touched a low price of $14.50.
Recently in News on December 9, 2020, Five Prime to Present Phase 2 FIGHT Trial Results of Bemarituzumab at American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Virtual Annual Symposium. Detailed results of the Phase 2 FIGHT trial have been accepted for late breaker presentation during the Esophageal and Gastric cancer oral abstract session on January 15, 2021. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Five Prime Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $18.29 on 01/04/21, with the lowest value was $14.50 for the same time period, recorded on 01/13/21.
Five Prime Therapeutics Inc. (FPRX) full year performance was 194.49%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Five Prime Therapeutics Inc. shares are logging -39.43% during the 52-week period from high price, and 754.86% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.75 and $24.70.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1236383 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Five Prime Therapeutics Inc. (FPRX) recorded performance in the market was -12.05%, having the revenues showcasing 152.28% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 625.48M, as it employees total of 87 workers.
Analysts verdict on Five Prime Therapeutics Inc. (FPRX)
During the last month, 0 analysts gave the Five Prime Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 10.54, with a change in the price was noted +10.27. In a similar fashion, Five Prime Therapeutics Inc. posted a movement of +218.98% for the period of last 100 days, recording 1,719,277 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for FPRX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Five Prime Therapeutics Inc. (FPRX): Technical Analysis
Raw Stochastic average of Five Prime Therapeutics Inc. in the period of last 50 days is set at 51.78%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 7.10%. In the last 20 days, the company’s Stochastic %K was 20.06% and its Stochastic %D was recorded 29.67%.
Let’s take a glance in the erstwhile performances of Five Prime Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -12.05%. Additionally, trading for the stock in the period of the last six months notably improved by 143.65%, alongside a boost of 194.49% for the period of the last 12 months. The shares increased approximately by -7.88% in the 7-day charts and went down by -7.31% in the period of the last 30 days. Common stock shares were driven by 152.28% during last recorded quarter.